Silmitasertib with interferon (an AI-found idea)
An AI model's prediction that worked in lab cells; not yet tested in animals or people.
Also called or includes: C2S-Scale, CX-4945, Gemma cancer therapy, AI-discovered cancer treatment
What studies found
In 2025 an AI model built by Google and Yale (C2S-Scale) screened more than 4,000 drugs and predicted that the experimental drug silmitasertib, given with low-dose interferon, would make tumor cells easier for the immune system to see. In human cells in the lab, the drug alone did nothing, interferon alone had a small effect, and together they raised the markers immune cells recognize by about 50%.
The catch
Lab cells only. The researchers call it an early first step that still needs animal studies and then trials in people, and the work had not been peer reviewed when announced.
What to do
Nothing to ask for or take yet. If you want to try new approaches, ask your oncologist about clinical trials.
Sources
Rung 1 of 5, Unproven: Lab or animal data only, or never directly tested in people. How we score
Spotted an error, or want something else rated? Tell us and we’ll check it against the sources.
Related
- Active surveillance for low-risk prostate cancerRung 5 · EstablishedWith your doctorRung 5 · EstablishedTreatmentWith your doctor
- Gene-matched drugs for metastatic prostate cancerRung 5 · EstablishedWith your doctorRung 5 · EstablishedTreatmentWith your doctor
- PSMA radioligand therapy (Pluvicto)Rung 5 · EstablishedWith your doctorRung 5 · EstablishedTreatmentWith your doctor
- Standard treatment from your oncology teamRung 5 · EstablishedWith your doctorRung 5 · EstablishedTreatmentWith your doctor
- Structured exercise after colon cancerRung 5 · EstablishedYou can do thisRung 5 · EstablishedTreatmentYou can do this
Every option we rated, or follow one cancer step by step: breast cancer, colorectal cancer, lung cancer and prostate cancer.